{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:24:36Z","timestamp":1648686276121},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1097\/rlu.0000000000000936","type":"journal-article","created":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T11:51:24Z","timestamp":1438948284000},"page":"899-901","source":"Crossref","is-referenced-by-count":1,"title":["FDG PET\/CT Manifestation of Rare Widespread Metastatic Chemoradiation-Refractory Thymic Squamous Cell Carcinoma"],"prefix":"10.1097","volume":"40","author":[{"given":"Aaron","family":"VanDreel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darshan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajyasree","family":"Emmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-18-20210204","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/JTO.0b013e3181e392a8","article-title":"Insulin-like growth factor-1 receptor expression in thymic malignancies.","volume":"5","author":"Girard","year":"2010","journal-title":"J Thorac Oncol"},{"key":"R2-18-20210204","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1002\/cncr.25367","article-title":"Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas.","volume":"116","author":"Zucali","year":"2010","journal-title":"Cancer"},{"key":"R3-18-20210204","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1093\/annonc\/mds147","article-title":"Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas.","volume":"23","author":"Mimae","year":"2012","journal-title":"Ann Oncol"},{"key":"R4-18-20210204","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.athoracsur.2013.04.078","article-title":"Surgical treatment and prognosis of thymic squamous cell carcinoma: a retrospective analysis of 105 cases.","volume":"96","author":"Zhao","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"R5-18-20210204","first-page":"153","article-title":"Thymomas and thymic carcinomas: prognostic factors and multimodal management.","volume":"62","author":"Moser","year":"2014","journal-title":"Thorac Cardiovasc Surg"},{"key":"R6-18-20210204","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1470-2045(13)70596-5","article-title":"Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial.","volume":"15","author":"Rajan","year":"2014","journal-title":"Lancet Oncol"},{"key":"R7-18-20210204","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/modpathol.2011.178","article-title":"Extrathoracic metastases of thymic origin: a review of 35 cases.","volume":"25","author":"Vladislav","year":"2012","journal-title":"Mod Pathol"},{"key":"R8-18-20210204","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.lungcan.2013.08.003","article-title":"Role of combined 18F-FDG-PETCT for predicting the WHO malignancy grade of thymic epithelial tumors: a multicenter analysis.","volume":"82","author":"Lococo","year":"2013","journal-title":"Lung Cancer"},{"key":"R9-18-20210204","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1093\/ejcts\/ezt263","article-title":"18F-fluorodeoxyglucose positron emission tomographycomputed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.","volume":"44","author":"Toba","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"R10-18-20210204","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fendo.2014.00224","article-title":"IGF-IR targeted therapy: past, present and future.","volume":"5","author":"Janssen","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R11-18-20210204","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.neo.2015.03.001","article-title":"IGF-1R inhibition activates a YESSFK bypass resistance pathway: rational basis for co-targeting IGF-1R and YesSFK kinase in rhabdomyosarcoma.","volume":"17","author":"Wan","year":"2015","journal-title":"Neoplasia"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000000936","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:13:00Z","timestamp":1620972780000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201511000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000000936","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}